Clinical Trial Update: Loteprednol Etabonate in an Ophthalmic Base vs Vehicle for the Treatment of Inflammation Following Cataract Surgery [Phase 3]

View source ↗

Summary

Phase 3 trial comparing loteprednol etabonate ophthalmic formulation in an ophthalmic base versus vehicle for treating ocular inflammation after cataract surger…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Inflammation

Drugs mentioned

• Lotemax (Loteprednol etabonate)

Snippet

Sponsor: Bausch & Lomb Incorporated | Conditions: Ocular Inflammation | Phase 3 | Status: COMPLETED | Results posted: 2010-09-23